Navigation Links
Potential lung cancer vaccine shows renewed promise
Date:3/20/2014

(SACRAMENTO, Calif.) Researchers at UC Davis have found that the investigational cancer vaccine tecemotide, when administered with the chemotherapeutic cisplatin, boosted immune response and reduced the number of tumors in mice with lung cancer. The study also found that radiation treatments did not significantly impair the immune response. The paper was published on March 10 in the journal Cancer Immunology Research, an American Association for Cancer Research (AACR) publication.

Though tecemotide, also known as Stimuvax, has shown great potential at times, the recent Phase III trial found no overall survival benefit for patients with non-small cell lung cancer (NSCLC). However, further analysis showed one group of patients, who received concurrent chemotherapy and radiation followed by tecemotide, did benefit from the vaccine. As a result, tecemotide's manufacturer, Merck KGaA, is sponsoring additional post-clinical animal and human studies, so far with good results.

"There aren't any good options for patients with inoperable stage III lung cancer following mainline chemotherapies," said UC Davis Professor of Medicine and lead author Michael DeGregorio. "We are looking at tecemotide as a potential maintenance therapy to prolong survival and improve quality of life."

Tecemotide activates an immune response by targeting the protein MUC1, which is often overexpressed in lung, breast, prostate and other cancers. The vaccine stimulates production of interferon gamma and MUC1-targeted killer T-lymphocytes, which seek out and destroy MUC1 cancer cells.

The team, which included investigators from the UC Davis School of Veterinary Medicine and the Department of Radiation Oncology, wanted to know if cisplatin/tecemotide treatments, along with radiation therapy, could boost the immune response and alter lung cancer's trajectory, stabilizing the disease.

The study produced a number of positive results. Tecemotide
'/>"/>

Contact: Dorsey Griffith
dorsey.griffith@ucdmc.ucdavis.edu
916-734-9118
University of California - Davis Health System
Source:Eurekalert

Page: 1 2

Related biology news :

1. Study suggests potential association between soy formula and seizures in children with autism
2. Researchers find potential target for drug to treat allergic asthma
3. UTMB collaborates on program targeting potential bioterrorist pathogens Ebola and Marburg
4. 3D microgels on-demand offer new potential for cell research
5. Climate engineering: Minor potential, major side effects
6. Greener aerogel technology holds potential for oil and chemical clean-up
7. Sustainable use of energy wood resources shows potential in North-West Russia
8. Study finds potential solution for feeding, swallowing difficulties in children with autism
9. UK failing to harness its bioenergy potential
10. Pond-dwelling powerhouses genome points to its biofuel potential
11. New finding points to potential options for attacking stem cells in triple-negative breast cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/14/2015)... -- NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or ... growing mobile commerce market, announces that its Wocket® smart ... Design Awards under the category  ,Product Design – Technology,. ... are part of a global multi-disciplinary awards program. The ... marketplace, industry and judging panel. Winners will be announced ...
(Date:4/8/2015)... 2015  Infinisource, a leading provider of SaaS-based Human ... a leading supplier of biometric identification and security ... most advanced biometrically-enabled time clock, the companies announced ... is setting a bold, new standard for the ... small and mid-size employer. When connected to the ...
(Date:4/2/2015)... April 2, 2015 Fingerprint Cards ... sensor FPC1025 from the distributor World Peace Industrial Group ... Q2 2015 although the major part of the shipments ... be used by smartphone manufacturers in China ... included in the communicated revenue guidance of + 1 000 ...
Breaking Biology News(10 mins):NXT-ID's Wocket Smart Wallet Nominated for 2015 New York Design Awards in 'Product Design- Technology' 2NXT-ID's Wocket Smart Wallet Nominated for 2015 New York Design Awards in 'Product Design- Technology' 3iSolved Time Clock Offers Unmatched Accuracy due to Morpho Biometrics 2iSolved Time Clock Offers Unmatched Accuracy due to Morpho Biometrics 3Fingerprint Cards Receives Touch Fingerprint Sensor Order of SEK 110 Million 2
... born every day in the brain,s hippocampus, but what controls ... 1 issue of Science , neuroscientists at the Johns ... of new cells, which depends on brain activity, also depends ... in the cell,s genetic material. "How is it ...
... The evolutionary history of diatoms -- abundant oceanic plankton ... air each year -- needs to be rewritten, according to ... sudden rise in species numbers, diatoms abruptly declined about 33 ... cooling. , The study is published in the Jan. 8 ...
... gas, believed to be among the cleanest forms of ... in home appliances such as stove tops and water ... issue (Volume 25, Number 10) of Environmental Engineering ... Ann Liebert, Inc. The paper is available free online ...
Cached Biology News:Growth of new brain cells requires 'epigenetic' switch 2Decline of carbon-dioxide-gobbling plankton coincided with ancient global cooling 2
(Date:4/20/2015)... 20, 2015 - Development of ... Using the VOLVOX Platform - To be Presented on ... -  Supramolecular Assembly of Antibody-drug Conjugates Using an anti-HER2 ... on Sunday, Apr 19, 1:00 PM EST ... program, today announced that the company,s novel computational platform ...
(Date:4/20/2015)... Whitehouse Laboratories is pleased and overly excited ... Food and Drug Administration (FDA) inspection and received no ... GMP compliance inspection, as based upon 21CFR Parts 210 ... 6th and was granted NAI (no action indicated) status. ... Good Manufacturing Practice (GMP) quality system required by the ...
(Date:4/17/2015)... , April 17, 2015 /PRNewswire/ - SQI Diagnostics ... and diagnostics company that develops and commercializes proprietary ... today announced that it has received approval from ... of 5,126,044 outstanding common share purchase warrants ("the ... connection with the Company,s May 2013 private placement ...
(Date:4/17/2015)... April 17, 2015 BellBrook Labs ... marketing support for the powerful Orthogonal Pooled Screening ... Genomics Center at the Lankenau Institute for Medical ... is to measurably improve successful drug discovery outcomes ... offering rare, drug-like libraries available nowhere else, coupled ...
Breaking Biology Technology:Invictus Oncology Announces Two Posters to be Presented Describing its Platform Technology on Supramolecular Therapeutics at the American Association for Cancer Research Annual Meeting, 2015 2Whitehouse Laboratories Completes FDA Inspection with No Form 483 – No Observations 2Whitehouse Laboratories Completes FDA Inspection with No Form 483 – No Observations 3SQI Diagnostics to Extend Warrant Expiry 2SQI Diagnostics to Extend Warrant Expiry 3BellBrook Labs and Lankenau Institute Partner to Accelerate Drug Discovery using Orthogonal Pooled Screening 2
... of what may await them on Christmas morning. For me, December ... vying for a place at February's DEMO@15 show. While ... or so companies that will debut at the show, there are ... the conference gems we can unwrap now. , ,One such ...
... has received an undisclosed piece of its $8.5 million financing ... rare diseases, the company said. , ,The investment from a ... forming a new company, ZyStor, to buy its technology. , ... the Wisconsin investment that caught its attention. ...
... has almost finished teaching its first class of students in ... it has gained recognition and the opportunity to lead other ... grant on Tuesday of $495,000 from the U.S. Department of ... program. The funds are earmarked for an initiative to distribute ...
Cached Biology Technology:An early Christmas gift 2Gateway Technical College pilots IBM training program 2
One-step, microplate or cuvet, colorimetric 530nm, detection limit 0.16mg/dL in serum or plasma. Procedure: 10 min....
One-step, microplate or cuvet, colorimetric, detection range 0.01 g/dL to 5 g/dL. Procedure: 5 min....
...
MSE ANTI CAN. CD3:FITC/RAT ANTI CD4:RPE...
Biology Products: